Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2021 and 2022.
-
Tight liquidity NBB
Cash and receivables cover 26 % of short-term debt in 2022; threshold 65 %.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2022
NOVALON from Liège, company number BE0877126557, closed financial year 2022 with a result of € -28.1 million after tax. For that financial year NOVALON recorded revenue of € 14.2 million and equity of € 9.2 million. Compared with financial year 2021, the result moved from € -32.7 million to € -28.1 million. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2023.
€ 9.2 million
▲ € 85.9 million vs 2021
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -28.1 million
▲ 14 % less loss than in 2021
Profit after tax over the fiscal year.
€ 18,495
▼ 99% vs 2021
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -28.1 million.
People and assets in 2022
5
Average over the fiscal year, from the social balance sheet.
€ 406,898
▲ 7% vs 2021
€ 81,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2022
€ 6.5 million
▲ 44% vs 2021
Loans from banks and other lenders, long and short.
€ 18.7 million
▲ 90% vs 2021
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 204 days on average.
€ 85,637
▲ 227% vs 2021
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | Change 2021 → 2022 | |
|---|---|---|---|
| Revenue | € 4,104,812 | € 14,215,303 | ▲ 246% |
| Profit after taxes | € -32,655,429 | € -28,094,074 | ▲ € 4.6 million |
| Equity | € -76,706,151 | € 9,221,509 | ▲ € 85.9 million |
| Total debts | € 112,763,535 | € 27,362,528 | ▼ 76% |
| Cash | € 3,010,649 | € 18,495 | ▼ 99% |
| Retained profit | € -85,564,248 | € -28,087,924 | ▲ € 57.5 million |
| Bank debt | € 4,504,595 | € 6,500,000 | ▲ 44% |
| Balance sheet total | € 36,057,384 | € 36,584,037 | ▲ 1% |
| Employees (FTE) | 5 | 5 |
By revenue, NOVALON ranks 1st of 5 companies with main activity “Vervaardiging van overige farmaceutische producten” in Liège that publish figures (fiscal year 2022).
Key figures of NOVALON, fiscal years 2021 to 2022, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2023 has not been filed yet; it was expected before 31 July 2024.
Ask about NOVALON the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to NOVALON?
What happened at NOVALON in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
NOVALON is active according to the CBE. Legal situation: Opening faillissement.
- David Horn Solomon stepped down as director. NBB
- SRL ALIUS MODI stepped down as director. NBB
- New annual accounts for financial year 2022: loss of € 28.1 million. Source: NBB ↗
- VAN ROMPAY MANAGEMENT BV stepped down as director. NBB
- David Horn Solomon became a director. NBB
- Capital increase of € 114 million, published in the Gazette. Source: Staatsblad ↗
- SRL ALIUS MODI became a director. NBB
- YIMA SRL stepped down as director. NBB
In short
From € 32.7 million loss in 2021 to € 28.1 million loss in 2022.
Management
Directors
According to the 2022 annual accounts
Managing director · represented by LEON VAN ROMPAY
since 2021 · until 2023
David Horn Solomon
Managing director
since 2023 · until 2025
since 2022 · until 2025
Director · represented by FRANCOIS FORNIERI
Also active at: LE BOCHOLTZ, VITAMINES EVENTS, GUSTA SPRL, ARDENTIA IMMO, IMMO LIEGE PERRON, VIAE, EOLE RACING EVENTS
since 2017 · until 2022
Establishments
Establishment units
Physical locations of this company
Rue Saint-Georges 5
4000 Liège
Rue Saint-Georges 5-7
4000 Liège
Active since 9 May 2012
Rue de l'Expansion 57
4400 Flémalle
Active since 26 June 2017
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Liège
Same main activity (Vervaardiging van overige farmaceutische producten), 7 active companies in Liège, largest first.
LABORATOIRES LOHMANN & RAUSCHER
€ 12.2 million revenue · 2025
€ 1.3 million gross margin · 2025
€ 726,952 gross margin · 2025
€ -1,410 gross margin · 2025
€ -5,116 gross margin · 2024
€ -18,644 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- MITHRA PHARMACEUTICALS(inbrengende vennootschap)
Capital increase
Source: Deed ↗- SA MITHRA PHARMACEUTICALS(apporteur (inbreng in natura van een deel van een schuldvordering))
Incorporation
Source: Deed ↗- FORNIERI Francesco dit François(inschrijver) 66.5%
- YIMA(oprichter) 33.5%
Details
- Company number
- 0877.126.557
- VAT number
- BE 0877.126.557
- Registered office
- Rue Saint-Georges 5, 4000 Liège
- Names & denominations
- NOVALON
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 3 November 2005
- Peppol
- Not registered
- Activities · NACE
Vervaardiging van overige farmaceutische producten
Vervaardiging van overige farmaceutische preparaten